The pluses and minuses of health IT mandates; Researchers slam diabetes drug class;

> Health IT mandates may make legislators feel good, but are they really a good idea? FierceHealthIT

> In the hardest-hitting assessment of diabetes meds this year, two Wake Forest University researchers say regulators should restrict use of the glitazone class of drugs--which includes the long-suffering Avandia. FiercePharma

> The risk of stroke among patients taking antipsychotics may be more widespread than we thought. British researchers are saying that the risk accompanies all antipsychotics--not just the newer "atypicals" like Abilify and Zyprexa, as once thought. FiercePharma

> In the near future, it should become increasingly common for patients to collect personal healthcare data such as glucose levels or blood pressure readings with a specialized device--then shunt it easily to a server or website. FierceHealthIT

And Finally... The new trend in drug marketing isn't drug marketing at all. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.